Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

DOHMEN NEWS

Learn what's happening in the world of Dohmen and our clients
November 17, 2017

Dohmen recognized by Colorado BioScience Association

Dohmen Life Science Services was awarded the “Business Partner of the Year” Award by the Colorado BioScience Association (CBSA).
learn more
November 06, 2017

Dohmen sponsors 19th annual HHS SBIR/STTR Conference: In the Heartland

The Dohmen team will join experts from the U.S. Department of Health & Human Services and hundreds of healthcare innovators at the 19th Annual HHS SBIR/STTR Conference, November 7-9, in Milwaukee, Wis.
learn more
October 20, 2017

Dohmen chairs World Congress Rare Disease Market Access and Commercialization Summit

Dohmen Life Science Services to lead important industry discussions in in Boston, MA.
learn more
October 06, 2017

Dohmen sponsors NORD Rare Summit, October 16-17

DLSS heads to Washington, DC for NORD Rare Disease and Orphan Products Breakthrough Summit.
learn more
September 26, 2017

Dohmen promotes value of integrated patient services model at CBI Hub & SPP Conference

Today Dohmen Life Science Services (DLSS) will join fellow industry leaders at the 9th CBI Hub and SPP Model Optimization Conference in San Diego.
learn more
September 21, 2017

Dohmen brings clarity to ever-changing regulations & guidelines at recent MDRP Summit

Dohmen Life Science Services showcased its expertise as a leading business process outsourcer and consulting provider at the 2017 Medicaid Drug Rebate Program (MDRP), hosted recently in Chicago.
learn more
September 13, 2017

Dohmen releases new white paper on how better patient understanding leads to improved outcomes

New insights from clinical care experts and patient advocacy organizations call attention to the importance of understanding the unknown and unmet needs of the patient journey.
learn more
September 12, 2017

Dohmen proudly supports upcoming Global Genes 2017 Rare Patient Advocacy Summit

Rare diseases affect 1 in 10 Americans - that’s roughly 30 million people. Every day Dohmen Life Science Services (DLSS) aims to reduce the burden of disease by offering patient services and support on behalf of orphan drug manufacturers.
learn more
Next >